EUVIMEDEUVIMED entdecken
Crossref

Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine

Giorgia Sciacca

Advanced Neurology · 28.05.2026 · 026210021

DOI: 10.36922/an026210021 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Neurology, online erschienen am 28.05.2026. Verfasst von Giorgia Sciacca.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Sciacca, G. (2026). Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine. Advanced Neurology, 0(0), 026210021. https://doi.org/10.36922/an026210021

Vancouver

Sciacca G. Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine. Advanced Neurology. 2026;0(0):026210021. doi:10.36922/an026210021

BibTeX
@article{Sciacca2026,
  author = {Sciacca, Giorgia},
  title = {Targeting α-synuclein in Parkinson’s disease and Lewy Body Disorders: A new era of precision medicine},
  journal = {Advanced Neurology},
  year = {2026},
  volume = {0},
  number = {0},
  pages = {026210021},
  doi = {10.36922/an026210021}
}
Kostenlos starten →